홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3,3-Dimethyl-1-butyne → (2-Bromo-phenyl)-(3-tert-butyl-oxiranyl)-methanol

HRID 883750
인쇄

반응식

HRID 883750 반응식
B(C1CCCCC1)C1CCCCC1.[CH3:14][C:15]([CH3:19])([CH3:18])[C:16]#[CH:17].[Zn](CC)CC.[Br:25][C:26]1[CH:33]=[CH:32][CH:31]=[CH:30][C:27]=1[CH:28]=[O:29].CC([O:37]C([C@H](O)[C@@H](O)C(OC(C)C)=O)=O)C>CC(O[Ti](OC(C)C)(OC(C)C)OC(C)C)C>[Br:25][C:26]1[CH:33]=[CH:32][CH:31]=[CH:30][C:27]=1[CH:28]([CH:17]1[CH:16]([C:15]([CH3:19])([CH3:18])[CH3:14])[O:37]1)[OH:29]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 135123,3-Dimethyl-1-butyneHCID 811292-BromobenzaldehydeHCID 6453580Diisopropyl tartrateHCID 15879360CID 15879360HCID 178418750HCID 178418750, 화합물

생성물 1

HCID 72961412(2-Bromo-phenyl)-(3-tert-butyl-oxiranyl)-methanol수율 78%

시약·촉매·용매

1
HCID 178460666HCID 178460666, 화합물촉매

실험 절차

The product was prepared by General procedure T using 50 mg (0.28 mmol) Cy2BH, 35 μL (0.28 mmol) 3,3-dimethyl-1-butyne, 0.39 mL (0.78 mmol, 2.0 M in hexanes) Et2Zn, 2.4 mg (0.01 mmol) (−)-MIB, 29 μL (0.25 mmol) o-bromobenzaldehyde, 0.25 mL (0.25 mmol, 1.0 M in hexanes) Ti(OiPr)4, and 63 μL (0.30 mmol) (+)-DIPT. The crude product was purified by column chromatography (5% ethyl acetate in hexanes) to afford the title compound in 78% yield (55 mg, 0.19 mmol). threo-diastereomer: Colorless oil. [α]D20=−65.8 (c=0.40, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.90 (s, 9H), 2.55 (d, 1H, J=5.2 Hz), 3.08 (m, 2H), 5.00 (t, 1H, J=4.6 Hz), 7.18 (t, 1H, J=7.6 Hz), 7.37 (t, 1H, J=7.5 Hz), 7.55 (d, 1H, J=7.9 Hz), and 7.61 (d, 1H, J=7.3 Hz) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 25.7, 30.6, 58.2, 65.2, 71.7, 122.0, 127.88, 127.94, 129.4, 132.8, and 140.0 ppm; IR (neat): 3418, 3060, 2957, 2872, 2343, 1568, 1469, 1437, 1396, 1365, and 1190 cm−1; HRMS-CI m/z 267.0368 [(M−OH)+; calcd for C13H16BrO: 267.0385]. erythro-diastereomer: Colorless oil. [α]D20=−55.5 (c=0.53, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.84 (s, 9H), 2.42 (br d, 1H, J=2.1 Hz), 2.85 (br d, 1H, J=2.3 Hz), 3.29 (t, 1H, J=2.4 Hz), 5.40 (br s, 1H), 7.17 (t, 1H, J=7.4 Hz), 7.34 (t, 1H, J=7.4 Hz), 7.51 (d, 1H, J=7.7 Hz), and 7.54 (d, 1H, J=8.0 Hz) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 25.7, 30.3, 56.5, 62.3, 69.1, 122.1, 127.7, 127.9, 129.4, 132.6, and 138.9 ppm; IR (neat): 3426, 3060, 2958, 2861, 1631, 1590, 1586, 1467, 1439, 1390, and 1364 cm−1; HRMS-CI m/z 267.0368 [(M−. OH)+; calcd for C13H16BrO: 267.0385].

후처리

  1. customThe product was prepared by General procedure T
  2. customThe crude product was purified by column chromatography (5% ethyl acetate in hexanes)

출처 및 근거

ORD 기록
ord-234ea3e1e09a46628463dc5e09f5332f
출처 데이터셋
uspto-grants-2012_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08236976B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트